|Name||Clozapine N-oxide (CNO) (freebase)|
|Alternative names||CNO, CNO freebase|
|Customer comments|| |
Your technical review on CNO stability, solubility and use in the lab has been really helpful to my group. Verified customer
Exactly as described - Clozapine N-oxide (CNO) (freebase) does exactly what it should. Great product and company. Verified customer, Istituto Italiano di Tecnologia
|Description||Prototypical DREADD activator. Clozapine metabolite.|
Clozapine N-oxide: Scientist Approved
Clozapine N-oxide (CNO) (freebase) product vial image | Hello Bio
|Biological description|| |
Clozapine N-oxide CNO) is the prototypical chemical actuator for various DREADDs. It is a metabolite of the atypical antipsychotic clozapine.
CNO activates the excitatory Gq- coupled DREADDs: hM3Dq, hM1Dq and hM5Dq (pEC50 values are 7.26 and 8.61 at hM3Dq and hM1Dq respectively).
The hM3Dq DREADD is typically used for enhancing neuronal firing and activity (Gq- signaling in neuronal and non-neuronal cells).
‘Inhibitory’ (Gi- coupled) DREADDs:
CNO also activates the inhibitory hM4Di and hM2Di Gi-coupled DREADDs (pEC50 = 6.89 at hM4Di).
The hM4Di DREADD is the most commonly used inhibitory DREADD and is used for neuronal silencing.
Gs and β-arrestin coupled DREADDs:
CNO also activates the Gs- coupled DREADD (GsD) and the β-arrestin preferring DREADD: rM3Darr (Rq(R165L).
Care must therefore be taken in experimental design and proper controls should be incorporated, for example, the use of non-DREADD expressing animals may be appropriate (see Mahler and Aston-Jones (2018)).
Clozapine N-oxide (CNO) dihydrochloride is water soluble and easier to solubilise and handle. Our stability studies have found that this product does not precipitate in aqueous solution unlike the freebase form of CNO (which due to its inherent chemical properties requires careful handling, has been shown in the literature to precipitate in solution under certain conditions and batch to batch variation in solubility can occur).
Solubility & Handling
|Storage instructions||Room temperature (desiccate)|
|Solubility overview||Soluble in DMSO (100mM).|
Due to the inherent chemical properties of CNO, this product requires careful handling – our guidelines are detailed below.
Batch to batch variation in solubility can occur. Some batches are water soluble but ongoing solubility in aqueous solutions can be unpredictable.
CNO has been shown in the literature to precipitate in aqueous solution and following further solubility studies that we have undertaken, we have found that precipitation occurred in some concentrated (100mM) samples of CNO dissolved in water.
We therefore recommend using DMSO when working with CNO freebase. If you need to work with aqueous solutions, you should use CNO dihydrochloride which is easier to solubilize and handle than CNO freebase. Our stability studies have found that this product does not precipitate in solution.
CNO (freebase) is soluble in DMSO to 100 mM.
Storage of solutions in DMSO
Solubilizing CNO (freebase) in aqueous solutions (e.g. water / saline)
We do not recommend using CNO freebase with aqueous solutions however, we provide these guidelines if you do:
When working with the compound in aqueous solutions, we recommend:
Our stability studies have shown that CNO in solution remains chemically stable (>99% purity by HPLC) for at least 4 weeks at room temperature.
Storage of solutions in aqueous solutions (e.g. water/saline
We recommend that you do not store aqueous solutions of CNO. However, if this is necessary:
If you find precipitate in your solution, gently heat your solution in a water bath to approx 40°C and the compound should readily re-dissolve. Always take care to ensure that the compound is completely dissolved before use.
CNO dihydrochloride is now available and is also water soluble. It is easier to solubilise and handle and unlike the freebase form of CNO, our stability studies have found that this product does not precipitate in solution.
|Important||This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.|
|Chemical name||8-Chloro-11-(4-methyl-4-oxido-1-pip erazinyl)-5H-dibenzo[b,e][1,4]diazepine|
References for Clozapine N-oxide (CNO) (freebase)
A Comparative Study of the Pharmacokinetics of Clozapine N-Oxide and Clozapine N-Oxide Hydrochloride Salt in Rhesus Macaques.Allen et al (2019) J Pharmacol Exp Ther 368(2) : 199-207
Pharmacokinetic and pharmacodynamic actions of clozapine-N-oxide, clozapine, and compound 21 in DREADD-based chemogenetics in mice.Jendryka et al (2019) Sci Rep. 9(1) : 4522
DREADDs: The Power of the Lock, the Weakness of the Key. Favoring the Pursuit of Specific Conditions Rather than Specific Ligands.Goutaudier et al (2019) eNeuro 6 : (5)
CNO Evil? Considerations for the Use of DREADDs in Behavioral Neuroscience.Mahler and Aston-Jones (2018) Neuropsychopharmacology doi: 10.1038 : npp.2017.299
DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs in Vitro and in VivoThompson et al (2018) ACS Pharmacol. Transl. Sci. 10.1021 : /acsptsci.8b00012
Pathway-Specific Chemogenetic Manipulation by Applying Ligand to Axonally Expressed DREADDsMartinez et al (2023) Vectorology for Optogenetics and Chemogenetics
Distinct Roles for Prefrontal Dopamine D1 and D2 Neurons in Social HierarchyXing B et al (2022) J Neurosci 42(2) : 313-324PubMedID: 34844989
Fear engrams and NPYergic circuit in the dorsal dentate gyrus determine remote fear memory generalizationStork et al (2022) Biorxiv : https://doi.org/10.1101/2022.04.26.489543
The dual role of dopamine in the modulation of information processing in the prefrontal cortex underlying social behaviorSotoyama H et al (2022) FASEB J 36(2) : e22160PubMedID: 35064699
Single-cell resolution analysis of the crosstalk between chemogenically activated astrocytes and microgliaKim et al (2021) bioRxiv https://doi.org/10.1101/2020.04.27.064881 : doi